Figure 1: MFCC scheme showing four distinct fragment systems employed in the present study: (A) etilclopride plus amino acid residue with conjugated caps; (B) amino acid residue with conjugated caps; (C) eticlopride plus conjugated caps; (D) conjugated caps only.